Many people like to consider Monsanto (NYSE: MON) part of the brave new world of biotech. However, the company has long been shrouded in controversy, and there could be more in store.
Full story
sábado, 24 de marzo de 2007
Suscribirse a:
Comentarios de la entrada (Atom)

No hay comentarios.:
Publicar un comentario